Influenza vaccine immunity shaped by human-like influenza epitopes

由类人流感表位形成的流感疫苗免疫力

基本信息

  • 批准号:
    9754778
  • 负责人:
  • 金额:
    $ 23.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-02 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The principle strategy to prevent seasonal influenza infection is immunization to generate virus neutralizing antibodies. The magnitude and quality of vaccine-induced neutralizing antibody responses depend to a significant extent on the sum of diverse T cell responses activated through the presentation of vaccine or infection-derived sequences. Carefully shaped effector and regulatory T cell responses can help generate protective humoral immunity, but an imbalance favoring regulatory mechanisms may impede antigen-specific B cell responses and limit the development of high affinity antibodies, resulting in poor vaccine efficacy. While much has been learned about influenza vaccine-specific effector T cell responses, most studies have largely overlooked mechanisms that diminish vaccine efficacy. We developed computational methods for identification of potential regulatory T cell-inducing epitopes in pathogen sequences that are highly cross-conserved with human protein sequences. Based on our preliminary studies showing that Treg activation and function is linked to viral T cell epitopes bearing homology to human sequences, we hypothesize that human-like epitopes in seasonal influenza virus stimulate suppressive mechanisms that limit vaccine efficacy. To test this hypothesis, we propose to conduct immune monitoring studies using an existing cell and serum bank from subjects immunized with the trivalent inactivated virus influenza vaccine over four consecutive years, beginning with the 2008-2009 influenza season. This unique cohort, spanning the pre- and post-2009 H1N1 pandemic eras, affords an opportunity to ask significant questions about changes in humoral and cellular immune responses to H1N1 and H3N2 vaccine strains within each season and from season to season. We will investigate associations between hemagglutination inhibition titers and frequencies of HA-specific CD4+ Tregs and circulating regulatory follicular T cells (cTfr). Additionally, we will evaluate the frequency and suppressive function of Treg and cTfr cells specific for human-like influenza A virus HA T cell epitopes in human vaccination. Identification of Treg-/Tfr-activating epitopes associated with limited antibody responses may begin to uncover a mechanism of immune-evasion underappreciated in seasonal influenza vaccination. Moreover, it may spur novel vaccine design strategies that increase the efficacy of influenza vaccines and vaccines in general.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonard Moise其他文献

Leonard Moise的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonard Moise', 18)}}的其他基金

Development of a Non-Tolerogenic Anti-DEC-205 Vaccine Delivery Platform
非耐受性抗 DEC-205 疫苗递送平台的开发
  • 批准号:
    8378745
  • 财政年份:
    2012
  • 资助金额:
    $ 23.03万
  • 项目类别:
Development of a Non-Tolerogenic Anti-DEC-205 Vaccine Delivery Platform
非耐受性抗 DEC-205 疫苗递送平台的开发
  • 批准号:
    7696406
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:
Development of a Non-Tolerogenic Anti-DEC-205 Vaccine Delivery Platform
非耐受性抗 DEC-205 疫苗递送平台的开发
  • 批准号:
    8501259
  • 财政年份:
  • 资助金额:
    $ 23.03万
  • 项目类别:
Development of a Non-Tolerogenic Anti-DEC-205 Vaccine Delivery Platform
非耐受性抗 DEC-205 疫苗递送平台的开发
  • 批准号:
    8114216
  • 财政年份:
  • 资助金额:
    $ 23.03万
  • 项目类别:
Development of a Non-Tolerogenic Anti-DEC-205 Vaccine Delivery Platform
非耐受性抗 DEC-205 疫苗递送平台的开发
  • 批准号:
    8300163
  • 财政年份:
  • 资助金额:
    $ 23.03万
  • 项目类别:

相似海外基金

Investigating how natural (ligand) and non-natural (antibody) affinity and dimersiation states affect the natural (ligand) and non-natural (antibody)
研究天然(配体)和非天然(抗体)亲和力和二聚状态如何影响天然(配体)和非天然(抗体)
  • 批准号:
    2869950
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Studentship
Evolution of antibody affinity modification in fishes
鱼类抗体亲和力修饰的演变
  • 批准号:
    RGPIN-2020-05979
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Immunogenetics of antibody affinity
抗体亲和力的免疫遗传学
  • 批准号:
    RGPIN-2019-05047
  • 财政年份:
    2022
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Immunogenetics of antibody affinity
抗体亲和力的免疫遗传学
  • 批准号:
    RGPIN-2019-05047
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Evolution of antibody affinity modification in fishes
鱼类抗体亲和力修饰的演变
  • 批准号:
    RGPIN-2020-05979
  • 财政年份:
    2021
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Immunogenetics of antibody affinity
抗体亲和力的免疫遗传学
  • 批准号:
    RGPIN-2019-05047
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Evolution of antibody affinity modification in fishes
鱼类抗体亲和力修饰的演变
  • 批准号:
    RGPIN-2020-05979
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
    Discovery Grants Program - Individual
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性
  • 批准号:
    10080587
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性
  • 批准号:
    10155411
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 23.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了